COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 1293: Articles 12921-12930  | Next

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., Oldridge, D. A., Giles, J. R., Weirick, M. E., McAllister, C. M., Awofolaju, M., Tanenbaum, N., Drapeau, E. M., Dougherty, J., Long, S., D'Andrea, K., Hamilton, J. T., McLaughlin, M., Williams, J. C., Adamski, S., The UPenn COVID Processing Unit, , Kuthuru, O., Frank, I., Betts, M. R., Vella, L. A., Grifoni, A., Weiskopf, D., Sette, A., Hensley, S. E., Davenport, M. P., Bates, P., Luning Prak, E. T., Greenplate, A. R., Wherry, E. J.
10.1101/2021.08.23.457229 — Posted: 2021-08-23
Induction of soluble platelet activation markers and FXIII deficiency promote COVID-19 severity
Al-Tamimi, A. O., Yusuf, A. M., Jayakumar, M. N., Ansari, A. W., Elhassan, M., AbdulKarim, F., Kannan, M., Halwani, R., Ahmad, F.
10.1101/2021.08.23.457378 — Posted: 2021-08-23
EFFECT OF EARLY TREATMENT WITH FLUVOXAMINE ON RISK OF EMERGENCY CARE AND HOSPITALIZATION AMONG PATIENTS WITH COVID-19: THE TOGETHER RANDOMIZED PLATFORM CLINICAL TRIAL
TOGETHER Trial, , Reis, G., Silva, E., Silva, D., Thabane, L., Milagres, A., Ferreira, T., dos Santos, C., Neto, A., Callegari, E., Savassi, L., Campos, V., Simplicio, M., Ribeiro, L., Oliveira, R., Harari, O., Forrest, J., Hinda, R., Sprague, S., McKay, P., Glushchenko, A., Rayner, C., Lenze, E., Reierson, A., Guyatt, G., Mills, E.
10.1101/2021.08.19.21262323 — Posted: 2021-08-23 Discussion: Onsite
Switching of OAS1 splicing isoforms mitigates SARS-CoV-2 infection
Iida, K., Ajiro, M., Muramoto, Y., Takenaga, T., Denawa, M., Kurosawa, R., Noda, T., Hagiwara, M.
10.1101/2021.08.23.457314 — Posted: 2021-08-23
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
Liu, Y., Arase, N., Kishikawa, J.-i., Hirose, M., Li, S., Tada, A., Matsuoka, S., Arakawa, A., Akamatsu, K., Ono, C., Jin, H., Kishida, K., Nakai, W., Kohyama, M., Nakagawa, A., Yamagishi, Y., Nakagami, H., Kumanogoh, A., Matsuura, Y., Standley, D. M., Kato, T., Okada, M., Fujimoto, M., Arase, H.
10.1101/2021.08.22.457114 — Posted: 2021-08-23 Discussion: Onsite | Offsite
Population birth outcomes in 2020 and experiences of expectant mothers during the COVID-19 pandemic: a Born in Wales mixed methods study using routine data
Jones, H., Seaborne, M., Cowley, L., Odd, D. E., Paranjothy, S., Akbari, A., Brophy, S.
10.1101/2021.08.23.21262209 — Posted: 2021-08-23
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia
Barchuk, A., Cherkashin, M., Bulina, A., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.
10.1101/2021.08.18.21262065 — Posted: 2021-08-23
Improving the reproduction number calculation by treating for daily variations of SARS-CoV-2 cases
Drewes, H., Flaeschner, G., Moeller, P.
10.1101/2021.08.15.21262071 — Posted: 2021-08-23
Comparison of the inhomogeneous SEPIR model and data from the COVID-19 outbreak in South Carolina
Granek, R., Tsori, Y.
10.1101/2021.08.15.21262074 — Posted: 2021-08-23
Gene-environment interaction analysis incorporating sex, cardiometabolic diseases, and multiple deprivation index reveals novel genetic associations with COVID-19 severity
Westerman, K. E., Lin, J., Sevilla-Gonzalez, M., Tadess, B., Manning, A. K., Marchek, C. J.
10.1101/2021.08.13.21261910 — Posted: 2021-08-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).